{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:14:30Z","timestamp":1789586070481,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Ministry of Science, ICT & Future Planning","award":["2017M3A9G2073551"],"award-info":[{"award-number":["2017M3A9G2073551"]}]},{"name":"Industrial Strategic Technology Development Program","award":["10067809"],"award-info":[{"award-number":["10067809"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejpb.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T11:48:42Z","timestamp":1518176922000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles"],"prefix":"10.1016","volume":"127","author":[{"given":"Hye-Rin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Nyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.02.014_b0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0190-9622(90)70015-A","article-title":"Intralesional cyclosporine in the treatment of psoriasis: a clinical, immunologic, and pharmacokinetic study","volume":"22","author":"Ho","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(88)91335-9","article-title":"Intralesional injection of cyclosporin in psoriasis","volume":"331","author":"Powles","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.02.014_b0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.293.6549.731","article-title":"Clearance of psoriasis with low-dose cyclosporine","volume":"293","author":"Griffiths","year":"1986","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejpb.2018.02.014_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.1990.tb02882.x","article-title":"Side effect profile of cyclosporin A in patients treated for psoriasis","volume":"122","author":"Krupp","year":"1990","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.02.014_b0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000210782","article-title":"Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study","volume":"1","author":"Hermann","year":"1988","journal-title":"Skin. Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0040","article-title":"Topical cyclosporine-A in the treatment of psoriasis","volume":"34","author":"Schauder","year":"1986","journal-title":"Clin. Res."},{"key":"10.1016\/j.ejpb.2018.02.014_b0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1989.tb07784.x","article-title":"Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations","volume":"120","author":"Baker","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.1992.01680160070006","article-title":"Intralesional cyclosporine for psoriasis: relationship of dose, tissue levels, and efficacy","volume":"128","author":"Burns","year":"1992","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(97)00117-X","article-title":"Transdermal delivery of cyclosporin-A using electroporation","volume":"50","author":"Wang","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2006.07.022","article-title":"Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A","volume":"326","author":"Liu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.02.014_b0065","doi-asserted-by":"crossref","first-page":"02B402","DOI":"10.1116\/1.4982826","article-title":"Feasibility of transdermal delivery of cyclosporine A using plasma discharges","volume":"12","author":"Kristof","year":"2017","journal-title":"Biointerphases"},{"key":"10.1016\/j.ejpb.2018.02.014_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10717540802518082","article-title":"Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations","volume":"16","author":"So","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.02.014_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","article-title":"Current status and future potential of transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2004","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ejpb.2018.02.014_b0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4155\/tde-2017-0028","article-title":"How can microneedles overcome challenges facing transdermal drug delivery?","volume":"8","author":"Donnelly","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2018.02.014_b0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","article-title":"Coated microneedles for transdermal delivery","volume":"117","author":"Gill","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0090","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.02.014_b0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans) dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0100","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.02.014_b0105","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/21645515.2016.1171440","article-title":"The success of microneedle-mediated vaccine delivery into skin","volume":"12","author":"Marshall","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ejpb.2018.02.014_b0110","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/jps.24159","article-title":"Coating solid dispersions on microneedles via a molten dip doating method: development and In Vitro evaluation for transdermal delivery of a water insoluble drug","volume":"103","author":"Ma","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.02.014_b0115","article-title":"Formulation of hydrophobic peptides for skin delivery via coated microneedles","author":"Zhao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.10.005","article-title":"Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: proof of concept","author":"Vora","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2015.12.038","article-title":"Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles","volume":"223","author":"Dangol","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.02.014_b0130","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/jps.20066","article-title":"A study of phase separation in peptide loaded HPMC films using Tzero modulated temperature DSC, atomic force microscopy, and scanning electron microscopy","volume":"93","author":"Hussain","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.02.014_b0135","series-title":"Scanning Electron Microscopy and X-ray Microanalysis","author":"Lawes","year":"1987"},{"key":"10.1016\/j.ejpb.2018.02.014_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","article-title":"Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects","volume":"128","author":"Arya","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.02.014_b0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1515\/amtm-2016-0009","article-title":"Multi-scale curvature tensor analysis of machined surfaces","volume":"36","author":"Bartkowiak","year":"2016","journal-title":"Arch. Mech. Tech. Mater."},{"key":"10.1016\/j.ejpb.2018.02.014_b0150","first-page":"714","article-title":"Advanced 3D laser microscopy for measurements and analysis of vitrified bonded abrasive tools","volume":"7","author":"Kaplonek","year":"2012","journal-title":"J. Eng. Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.02.014_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(97)00325-6","article-title":"Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A","volume":"161","author":"Gao","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.02.014_b0160","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1021\/jm00076a002","article-title":"Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations","volume":"36","author":"El Tayar","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2018.02.014_b0165","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.22814","article-title":"Effect of lipophilicity on the bioavailability of drugs after percutaneous administration by dissolving microneedles","volume":"101","author":"Ito","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.02.014_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11095-010-0097-7","article-title":"Two-layered dissolving microneedles for percutaneous delivery of peptide\/protein drugs in rats","volume":"28","author":"Fukushima","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.02.014_b0175","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3109\/03639045.2011.576426","article-title":"Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats","volume":"37","author":"Ito","year":"2011","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.02.014_b0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-5173(98)00066-0","article-title":"Oral administration of liposomes containing cyclosporine: a pharmacokinetic study","volume":"168","author":"Al-Meshal","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.02.014_b0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0168-3659(04)00171-3","article-title":"Transdermal delivery of desmopressin using a coated microneedle array patch system","volume":"97","author":"Cormier","year":"2004","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117314145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117314145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T20:26:58Z","timestamp":1550003218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117314145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"alternative-id":["S0939641117314145"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}